BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3861246)

  • 1. Release of platelet-activating factor in human leukemia.
    Foa R; Bussolino F; Ferrando ML; Guarini A; Tetta C; Mazzone R; Gugliotta L; Camussi G
    Cancer Res; 1985 Sep; 45(9):4483-5. PubMed ID: 3861246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines.
    Bussolino F; Foa R; Malavasi F; Ferrando ML; Camussi G
    Exp Hematol; 1984 Oct; 12(9):688-93. PubMed ID: 6333353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane and intracellular platelet-activating factor receptor expression in leukemic blasts of patients with acute myeloid and lymphoid leukemia.
    Donnard M; Guglielmi L; Turlure P; Piguet C; Couraud MJ; Bordessoule D; Denizot Y
    Stem Cells; 2002; 20(5):394-401. PubMed ID: 12351810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
    Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
    Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional platelet-activating factor receptors in immature forms of leukemic blasts.
    Reynaud S; Malissein E; Donnard M; Bordessoule D; Turlure P; Trimoreau F; Denizot Y
    Leuk Res; 2007 Mar; 31(3):399-402. PubMed ID: 16837045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for platelet-activating factor (PAF) is not detectable by flow cytometry on the surface of myeloid leukemic cells.
    Berdel WE; Kulimova E; Kolkmeyer A; Zühlsdorf M; Serve H; Büchner T; Oelmann E
    Ann Hematol; 2005 Nov; 84(12):771-3. PubMed ID: 16094532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of human leukemia by membrane antigen analysis with xenoantisera.
    Metzgar RS; Dowell BL; Lachman LB; Jones NH; George FW
    Cancer Res; 1981 Nov; 41(11 Pt 2):4781-85. PubMed ID: 6794906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils.
    Sánchez-Crespo M; Alonso F; Egido J
    Immunology; 1980 Aug; 40(4):645-55. PubMed ID: 6776037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1.
    Shikano M; Masuzawa Y; Yazawa K
    J Immunol; 1993 Apr; 150(8 Pt 1):3525-33. PubMed ID: 8468486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia.
    Arber DA; Jenkins KA; Slovak ML
    Am J Pathol; 1996 Oct; 149(4):1105-10. PubMed ID: 8863659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus.
    Camussi G; Tetta C; Coda R; Benveniste J
    Lab Invest; 1981 Mar; 44(3):241-51. PubMed ID: 7464048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of a new B-cell-associated surface antigen (BL7) detected by a monoclonal antibody in human leukemic disorders.
    Al-Katib A; Wang CY; Koziner B
    Cancer Res; 1985 Jul; 45(7):3058-63. PubMed ID: 3924396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 protein expression in human leukemia and lymphoma cells.
    Koníková E; Kusenda J
    Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
    Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
    Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.